首页|Assessing the inhibition efficacy of clinical drugs against the main proteases of SARS-CoV-2 variants and other coronaviruses
Assessing the inhibition efficacy of clinical drugs against the main proteases of SARS-CoV-2 variants and other coronaviruses
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
drug resistanceenzymatic activitymain proteaseSARS-CoV-2
Wenlong Zhao、Cecylia S.Lupala、Shifeng Hou、Shuxin Yang、Ziqi Yan、Shujie Liao、Xuefei Li、Nan Li
展开 >
Key Laboratory of Quantitative Synthetic Biology,Shenzhen Institute of Synthetic Biology,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen,China
University of Chinese Academy of Sciences,Beijing,China
NETL
NSTL
万方数据
